Kirkwood JM, Ibrahim JG, Sosman JA, Sondak VK, Agarwala SS, Ernstoff MS, et al. High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J Clin Oncol 2001 May 1;19(9):2370-80 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/11331315.
Compare quality appraisals for each clinical question
- What is the role of adjuvant systemic therapy in patients with resected stage II and stage III melanoma?